CN1970018A - Prescription for treating prostatitis and preparation process thereof - Google Patents
Prescription for treating prostatitis and preparation process thereof Download PDFInfo
- Publication number
- CN1970018A CN1970018A CN 200510125272 CN200510125272A CN1970018A CN 1970018 A CN1970018 A CN 1970018A CN 200510125272 CN200510125272 CN 200510125272 CN 200510125272 A CN200510125272 A CN 200510125272A CN 1970018 A CN1970018 A CN 1970018A
- Authority
- CN
- China
- Prior art keywords
- fry
- stir
- myrrha
- herba
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicinal composition for treating prostatitis and the process for preparing the composition.
Description
Chronic prostatitis is commonly encountered diseases, the frequently-occurring disease of male genitourinary system, especially be more common in blue or green middle-aged male, add up according to authoritative department, blue or green middle-aged male about 40%~60% more than 20 years old suffers from chronic prostatitis, the about elderly men more than 60%, 60 years old of male more than 50 years old is about suffers from prostatic hyperplasia in various degree more than 80%.The complicated clinical of chronic prostatitis, clinical common sympton, one is the symptom of paruria: frequent micturition, urgent micturition, urine retention, the urethra causalgia, urine is waited for, urinary incontinence, the urine bifurcated, the urine line is thin, hematuria; Two is the radiated pain symptom: lower abdominal distention pain, testicular pain, urethral irritation, lumbago etc.; Three is sexual dysfunction: unable, and sexual hypofunction, sexual impotence, premature ejaculation, hemospermia etc.; Four is neurasthenia symptom: weak, dizzy, insomnia and dreamful sleep, ademosyne etc.; Pathological changes such as conjunctivitis, arthritis appear in long-lasting prostatitis even can cause the allergy of health.The chronic prostatitis pathogenesis is roughly: 1. the acute prostatitis pathological changes seriously or do not give thorough treatment and transfer to chronic; 2. residual chronic prostatitis behind the acute urinary tract infection; Posterior urethritis, seminal vesiculitis or epididymitis cause that chronic prostatitis takes place.3. other position focus amygdala of whole body, dental caries, skin, respiratory tract, digestive tract infection make antibacterial along the hematogenous infection prostate; 4. adjacent lesion involves prostate through lymph; Catch cold etc. in the prostate part.5. sexual life is improper; Excessive as sexual life, the masturbation overfrequency, chamber does not save and makes down empty exhausted, the damp and hot heresy of unit, the kidney of taking advantage of a weak point, the bladder of making a bet has influenced due to the functioning of bladder function.6. long-distance by bike, ride, seat or the position etc. of squatting down, make pelvic congestion, irritable food; As drink, vinegar-pepper food etc. also can cause blood-stasis internal-depression to bring out prostatitis.
Prostatic hyperplasia is called prostate hyperplasia again.Pilosity is born in the old people more than 50 years old, according to statistics, and about its sickness rate can reach more than 80% in elderly men.The ratio that improves trouble hypertrophy disease along with the age also improves constantly.Modern medicine is not understood at present as yet fully to the cause of disease of prostatic hyperplasia disease, relatively more consistent at present thinks because composite factors such as endocrine hormone dysequilibrium cause glandular hyperplasia, back prolonged urethra bending, pressurized, bladder outlet are raised, dysuria occurs and increase the weight of lower urinary tract obstruction gradually, the urine pool slips, secondary infection, calculus, tumor, so that renal failure etc.The clinical manifestation of prostatic hyperplasia disease mainly is that carrying out property of dysuria increases the weight of.Increase for frequent micturition, especially nocturia in early days; Engendering urinates hesitates, and increase abdominal pressure and urinate, acraturesis, urine rheology segmentation fork, so that not to the utmost dripping, acute urine pool slips or urinary incontinence.Prostatic hyperplasia can also merge other pathological changes of urinary tract to the compressing of urethra, as the inflammation of urethra, bladder, and vesical calculus, diverticulum of bladder or the like, these pathological changes also can cause.And course of disease delay, therefore recurrence easily after treatment brings influence in various degree to patient's life, work, study.
The cause of disease of prostate onset, the pathology complexity, and antimicrobial drug is difficult for permeating in prostate, brings difficulty to clinical treatment.The factor that influences the Drug therapy chronic prostatitis mainly contains prostatic physiological location and physiological structure, prostatic fluid pH value, prostate antimicrobial factors, immune factor etc.How to seek, develop new active drug, improve its cure rate, be the important topic that domestic and international Urology Surgery educational circles and pharmaceutical industry need to be resolved hurrily always.Be about to march toward today of aging society in China's population composition, oneself becomes very urgent scientific research mission to satisfy needs that middle-older patient prevents and cures diseases.
Summary of the invention
Purpose of the present invention just provides a kind of treatment prostatitis Chinese medicine composition of determined curative effect.
Another object of the present invention provides the preparation method of this Chinese medicine composition.
Chinese medicine composition of the present invention is made up of active component or pharmaceutically acceptable carrier, and preferred active component is to be made by following raw materials by weight percent:
Semen Persicae (stir-fry) 3-7%, Myrrha (stir-fry) 3-7%, Radix Salviae Miltiorrhizae, 3-7%, Radix Paeoniae Rubra 3-7%, Flos Carthami 3-7%, Herba Lycopi 3-7%, Semen Vaccariae (stir-fry) 3-7%, Spina Gleditsiae 3-7%, Herba Patriniae 14-24%, Herba Taraxaci 14-24%, Fructus Toosendan 3-7%, Radix Angelicae Dahuricae 3-7%, Folium Pyrrosiae 6-14%, Fructus Lycii 3-7%
The present invention is by forming function blood circulation promoting and blood stasis dispelling, clearing away heat-damp and promoting diuresis by Semen Persicae (stir-fry), Myrrha (stir-fry), Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Flos Carthami, Herba Lycopi, Semen Vaccariae (stir-fry), Spina Gleditsiae, Herba Patriniae, Herba Taraxaci, Fructus Toosendan, the Radix Angelicae Dahuricae etc.Be used for the treatment of the chronic prostatitis due to blood stasis cohesion, the damp invasion of lower energizer and the doing well,improving of prostatic hyperplasia.Disease sees urgent micturition, dysurea, it is smooth to urinate, the sound of rain pattering is unclean etc.
The preparation technology that the present invention treats active component in the prostatitis compositions is as follows: above 14 flavors, and Myrrha, Spina Gleditsiae, the Radix Angelicae Dahuricae are ground into fine powder, and all the other ten decoct with water secondary simply, 2 hours for the first time, 1.5 hours for the second time, collecting decoction, filter, filtrate is concentrated into the thick paste that relative density is 1.25~1.30 (75~80 ℃), adds above-mentioned fine powder mixing, dry below 80 ℃, pulverize, add appropriate amount of auxiliary materials, granulate drying, granulate, compacting is wrapped film-coat, promptly in flakes.
The active component that the present invention treats the prostatitis compositions can be prepared into various pharmaceutically acceptable dosage forms with pharmaceutically acceptable carrier, the preferred oral form of administration, as solid dosage forms tablet, granule, capsule etc., liquid preparation such as oral liquid, decoction, medicated wine, mixture etc.Preferred tablet.
Accompanying drawing: be the process chart that proposes according to the present invention.
Concrete embodiment
Embodiment 1
Take by weighing following raw materials in weight: Semen Persicae (stir-fry) 3-7%, Myrrha (stir-fry) 3-7%, Radix Salviae Miltiorrhizae, 3-7%, Radix Paeoniae Rubra 3-7%, Flos Carthami 3-7%, Herba Lycopi 3-7%, Semen Vaccariae (stir-fry) 3-7%, Spina Gleditsiae 3-7%, Herba Patriniae 14-24%, Herba Taraxaci 14-24%, Fructus Toosendan 3-7%, Radix Angelicae Dahuricae 3-7%, Folium Pyrrosiae 6-14%, Fructus Lycii 3-7%
More than 14 flavors, Myrrha, Spina Gleditsiae, the Radix Angelicae Dahuricae are ground into fine powder, all the other ten decoct with water secondary simply, 2 hours for the first time, 1.5 hours for the second time, collecting decoction, filter, filtrate is concentrated into the thick paste that relative density is 1.25~1.30 (75~80 ℃), adds above-mentioned fine powder mixing, dry below 80 ℃, pulverize, add appropriate amount of auxiliary materials, granulate drying, granulate, compacting is wrapped film-coat, promptly in flakes.
Claims (3)
1, treats gynopathic composition and method of making the same, it is characterized in that: with the Chinese medicine material, Semen Persicae (stir-fry) 3-7%, Myrrha (stir-fry) 3-7%, Radix Salviae Miltiorrhizae, 3-7%, Radix Paeoniae Rubra 3-7%, Flos Carthami 3-7%, Herba Lycopi 3-7%, Semen Vaccariae (stir-fry) 3-7%, Spina Gleditsiae 3-7%, Herba Patriniae 14-24%, Herba Taraxaci 14-24%, Fructus Toosendan 3-7%, Radix Angelicae Dahuricae 3-7%, Folium Pyrrosiae 6-14%, Fructus Lycii 3-7%.
2, according to claims 1, it is characterized in that above 14 flavors, Myrrha, Spina Gleditsiae, the Radix Angelicae Dahuricae are ground into fine powder, and all the other ten decoct with water secondary simply, 2 hours for the first time, 1.5 hours for the second time, collecting decoction, filter, filtrate is concentrated into the thick paste that relative density is 1.25~1.30 (75~80 ℃), adds above-mentioned fine powder mixing, dry below 80 ℃, pulverize, add appropriate amount of auxiliary materials, granulate drying, granulate, compacting is wrapped film-coat, promptly in flakes.
3, according to claims 1, comprise the pharmaceutically any pharmaceutical dosage form of acceptable.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510125272 CN1970018A (en) | 2005-11-22 | 2005-11-22 | Prescription for treating prostatitis and preparation process thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510125272 CN1970018A (en) | 2005-11-22 | 2005-11-22 | Prescription for treating prostatitis and preparation process thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1970018A true CN1970018A (en) | 2007-05-30 |
Family
ID=38111166
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200510125272 Pending CN1970018A (en) | 2005-11-22 | 2005-11-22 | Prescription for treating prostatitis and preparation process thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1970018A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102755563A (en) * | 2012-04-26 | 2012-10-31 | 中国中医科学院广安门医院 | Chinese medicinal composition for treating chronic prostatitis and preparation method thereof |
CN103656377A (en) * | 2013-11-27 | 2014-03-26 | 夏毓 | Traditional Chinese medicine medicament for internally and externally treating chronic prostatitis |
CN107648543A (en) * | 2017-11-21 | 2018-02-02 | 王洪波 | A kind of Chinese medicine composition for treating prostate and preparation method thereof |
CN109045156A (en) * | 2018-10-19 | 2018-12-21 | 山东宏济堂制药集团股份有限公司 | Chinese medicine composition, emplastrum and preparation method |
-
2005
- 2005-11-22 CN CN 200510125272 patent/CN1970018A/en active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102755563A (en) * | 2012-04-26 | 2012-10-31 | 中国中医科学院广安门医院 | Chinese medicinal composition for treating chronic prostatitis and preparation method thereof |
CN102755563B (en) * | 2012-04-26 | 2013-12-18 | 中国中医科学院广安门医院 | Traditional Chinese medicine composition for treating chronic prostatitis and preparation method thereof |
CN103656377A (en) * | 2013-11-27 | 2014-03-26 | 夏毓 | Traditional Chinese medicine medicament for internally and externally treating chronic prostatitis |
CN103656377B (en) * | 2013-11-27 | 2016-08-17 | 夏毓 | A kind of Chinese medicine of internal and external application chronic prostatitis |
CN107648543A (en) * | 2017-11-21 | 2018-02-02 | 王洪波 | A kind of Chinese medicine composition for treating prostate and preparation method thereof |
CN109045156A (en) * | 2018-10-19 | 2018-12-21 | 山东宏济堂制药集团股份有限公司 | Chinese medicine composition, emplastrum and preparation method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101884770B (en) | Chinese medicinal preparation for treating urolithiasis and preparation method thereof | |
CN101732660A (en) | Chinese medicinal preparation for treating prostate disease and preparation method thereof | |
CN101020015B (en) | Externally applied medicine for treating chronic prostatitis and prostatic hyperplasia | |
CN101695555B (en) | Medicament composition for treating prostatitis and prostatomegaly and preparation method thereof | |
CN1843491A (en) | Medicine composition for treating endometriosis | |
CN1970018A (en) | Prescription for treating prostatitis and preparation process thereof | |
CN103599472B (en) | A kind of Chinese medicine composition being used for the treatment of prostatic hyperplasia | |
CN103638231B (en) | Medicament for treating urticaria and preparation method of medicine | |
CN104173782A (en) | Medicine treating urinary calculi | |
CN102631630B (en) | Method for preparing traditional Chinese medicine (TCM) for treating intestine and stomach dyspepsia type colitis | |
CN104013813A (en) | Pharmaceutical composition for treating acute diarrhea | |
CN103751618A (en) | Calculus removing decoction for treating urinary calculus | |
CN103610765B (en) | A kind of inducing diuresis for treating stranguria syndrome calculus Chinese medicine pill | |
CN103301305A (en) | Traditional Chinese medicine for treating prostatic hyperplasia | |
CN102940716A (en) | Traditional Chinese medicine for treatment of uterine prolapse | |
CN113398211A (en) | Traditional Chinese medicine treatment method for cervical precancerous lesion | |
CN105148135A (en) | Traditional Chinese medicine preparation for treating chronic prostatitis | |
CN103520638B (en) | A kind of Traditional Chinese medicine compound composition for the treatment of prostate hyperplasia and preparation method thereof and application thereof | |
CN102824573B (en) | Medicine for treating prostatic diseases | |
CN103356797A (en) | Chinese medicine composition for treating kidney stone | |
CN103356959B (en) | Pharmaceutical composition for treating hyperplasia of mammary glands | |
CN102091256B (en) | Specific medicinal liquor and preparation thereof for treating prostatitis and inflammations of genitourinary system | |
CN103585575B (en) | Traditional Chinese medicine composition for gallstone and prostatic hyperplasia | |
CN100406043C (en) | A Chinese medicinal composition for treating prostatitis | |
CN105943744A (en) | Traditional Chinese medicine composition for treating retention of urine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Wang Qingzhong Document name: Notification before expiration of term |
|
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Wang Qingzhong Document name: Notification that Application Deemed to be Withdrawn |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |